Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Batlle

Showing results (141-150 of 155) with videos related to

Pageof 16
Sort By:
Plos One|April 25, 2024
Effect of SARS-CoV-2 S protein on the proteolytic cleavage of the epithelial Na+ channel ENaCGermán Ricardo Magaña-Ávila, Erika Moreno, Consuelo Plata, et al.
BMC Nephrology|October 6, 2011
Baseline characteristics of patients with chronic kidney disease stage 3 and stage 4 in Spain: the MERENA observational cohort studyAlberto Martínez-Castelao, José L Górriz, José M Portolés, et al.
Journal of the American Society of Nephrology : JASN|March 3, 2022
A Novel Soluble ACE2 Protein Provides Lung and Kidney Protection in Mice Susceptible to Lethal SARS-CoV-2 InfectionLuise Hassler, Jan Wysocki, Ian Gelarden, et al.
Iscience|August 23, 2024
Activation of limbal epithelial proliferation is partly controlled by the ACE2-LCN2 pathwayHuimin Jiang, Min Liu, Wending Yang, et al.
Plos One|November 29, 2007
High CO2 levels impair alveolar epithelial function independently of pHArturo Briva, István Vadász, Emilia Lecuona, et al.
Kidney International|December 11, 2002
Sodium ferric gluconate complex in hemodialysis patients. II. Adverse reactions in iron dextran-sensitive and dextran-tolerant patientsDaniel W Coyne, N Franklin Adkinson, Allen R Nissenson, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 30, 2020
Sound Science before Quick Judgement Regarding RAS Blockade in COVID-19Matthew A Sparks, Andrew South, Paul Welling, et al.
Biorxiv : the Preprint Server for Biology|December 16, 2022
Superiority of intranasal over systemic administration of bioengineered soluble ACE2 for survival and brain protection against SARS-CoV-2 infectionLuise Hassler, Jan Wysocki, Jared T Ahrendsen, et al.
Life Science Alliance|April 11, 2023
Intranasal soluble ACE2 improves survival and prevents brain SARS-CoV-2 infectionLuise Hassler, Jan Wysocki, Jared T Ahrendsen, et al.
Pharmacological Reviews|June 16, 2022
Kidney Angiotensin in Cardiovascular Disease: Formation and Drug TargetingHui Lin, Frank Geurts, Luise Hassler, et al.
Pageof 16

Showing results (141-150 of 155) with videos related to

Sort By:
Pageof 16
Plos One|April 25, 2024
Effect of SARS-CoV-2 S protein on the proteolytic cleavage of the epithelial Na+ channel ENaCGermán Ricardo Magaña-Ávila, Erika Moreno, Consuelo Plata, et al.
BMC Nephrology|October 6, 2011
Baseline characteristics of patients with chronic kidney disease stage 3 and stage 4 in Spain: the MERENA observational cohort studyAlberto Martínez-Castelao, José L Górriz, José M Portolés, et al.
Journal of the American Society of Nephrology : JASN|March 3, 2022
A Novel Soluble ACE2 Protein Provides Lung and Kidney Protection in Mice Susceptible to Lethal SARS-CoV-2 InfectionLuise Hassler, Jan Wysocki, Ian Gelarden, et al.
Iscience|August 23, 2024
Activation of limbal epithelial proliferation is partly controlled by the ACE2-LCN2 pathwayHuimin Jiang, Min Liu, Wending Yang, et al.
Plos One|November 29, 2007
High CO2 levels impair alveolar epithelial function independently of pHArturo Briva, István Vadász, Emilia Lecuona, et al.
Kidney International|December 11, 2002
Sodium ferric gluconate complex in hemodialysis patients. II. Adverse reactions in iron dextran-sensitive and dextran-tolerant patientsDaniel W Coyne, N Franklin Adkinson, Allen R Nissenson, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 30, 2020
Sound Science before Quick Judgement Regarding RAS Blockade in COVID-19Matthew A Sparks, Andrew South, Paul Welling, et al.
Biorxiv : the Preprint Server for Biology|December 16, 2022
Superiority of intranasal over systemic administration of bioengineered soluble ACE2 for survival and brain protection against SARS-CoV-2 infectionLuise Hassler, Jan Wysocki, Jared T Ahrendsen, et al.
Life Science Alliance|April 11, 2023
Intranasal soluble ACE2 improves survival and prevents brain SARS-CoV-2 infectionLuise Hassler, Jan Wysocki, Jared T Ahrendsen, et al.
Pharmacological Reviews|June 16, 2022
Kidney Angiotensin in Cardiovascular Disease: Formation and Drug TargetingHui Lin, Frank Geurts, Luise Hassler, et al.
Pageof 16